UFP TECHNOLOGIES INC UFPT
UFP TECHNOLOGIES INC (UFPT) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $602.8M at a 11.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.58 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.193 |
| Retained earnings / assets | 0.572 |
| EBIT / assets | 0.141 |
| Equity / liabilities | 1.833 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| UFPT | UFP TECHNOLOGIES INC | 7/9 | 6 | 28.7 | +19.5% |
| BVS | Bioventus Inc. | 8/9 | 0.54 | 35.9 | -0.9% |
| NVCR | NovoCure Ltd | 3/9 | -2.29 | — | +8.3% |
| ATRC | AtriCure, Inc. | 7/9 | 3.44 | — | +14.9% |
| GKOS | GLAUKOS Corp | 2/9 | 0.74 | — | +32.3% |
| ARAY | ACCURAY INC | 6/9 | -1.53 | — | +2.7% |
| IRTC | iRhythm Holdings, Inc. | 5/9 | 0.78 | — | +26.2% |
About UFP TECHNOLOGIES INC
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
FAQ
Is UFPT financially healthy?
UFP TECHNOLOGIES INC's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does UFPT pay a dividend?
No, UFP TECHNOLOGIES INC does not currently pay a dividend.
How profitable is UFPT?
In FY2025, UFP TECHNOLOGIES INC had a net margin of 11.3% and a return on equity of 16.1%.
Is UFPT overvalued or undervalued?
UFP TECHNOLOGIES INC trades at about 36.9× trailing earnings — above its 10-year norm (10-year range 17.1×–36.2×, median 26.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for UFPT?
The average Wall-Street price target for UFP TECHNOLOGIES INC is $324.50, about 0.6% above the recent price, from 2 analysts.
Is UFPT a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on UFP TECHNOLOGIES INC: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 28.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.